| Authors: |
Verma S; St Michael's Hospital and University of Toronto, Toronto, Ontario, Canada. Electronic address: subodh.verma@unityhealth.to., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom., Dicker D; Internal Medicine Department D, Hasharon Hospital-Rabin Medical Center, Petah Tikva, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hovingh GK; Novo Nordisk A/S, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Kahn SE; VA Puget Sound Health Care System and Department of Medicine, University of Washington, Seattle, Washington, USA., Kautzky-Willer A; Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Lingvay I; Division of Endocrinology, Department of Internal Medicine and Peter O'Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, Texas, USA., Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rasmussen S; Novo Nordisk A/S, Søborg, Denmark., Rathor N; Novo Nordisk A/S, Søborg, Denmark., Hoff ST; Novo Nordisk A/S, Søborg, Denmark., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. |
